Great summary mate. Thinking exact same. There is only $70k total value in sell side up to 44c in a $104M company.. It will push through and a re-rate once we know the metrics. Hopefully exceed the second guidance… I would think so or high side.
The change in tact and clinical evidence is compelling. IV is a global leader with runs on the board..
Very happy.
cheers
Monty
Ann: XPERIENCE study findings published, page-9
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.015(6.12%) |
Mkt cap ! $74.38M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.5¢ | 24.5¢ | $20.20K | 79.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9313 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 24500 | 1 |
View Market Depth
| Last trade - 15.30pm 20/06/2024 (20 minute delay) ? |
| NXS (ASX) Chart |